Journal article icon

Journal article

BET inhibition as a new strategy for the treatment of gastric cancer

Abstract:

Gastric cancer is one of the most common malignancies and a leading cause of cancer death worldwide. The prognosis of stomach cancer is generally poor as this cancer is not very sensitive to commonly used chemotherapies. Epigenetic modifications play a key role in gastric cancer and contribute to the development and progression of this malignancy. In order to explore new treatment options in this target area we have screened a library of epigenetic inhibitors against gastric cancer cell lines...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.18632/oncotarget.9766

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Target Discovery Institute
More by this author
Institution:
University of Oxford
Department:
Oxford, MPLS, Chemistry
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Target Discovery Institute
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Target Discovery Institute
Expand authors...
Boehringer Ingelheim More from this funder
Canada Foundation for Innovation More from this funder
Canadian Institutes for Health Research More from this funder
Expand funders...
Publisher:
Impacta Journals Publisher's website
Journal:
Oncotarget Journal website
Publication date:
2016-06-05
DOI:
EISSN:
1949-2553
URN:
uuid:9b5a6076-b144-48bf-8c20-d77e24273482
Source identifiers:
625525
Local pid:
pubs:625525

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP